comorbidities, mutations, and risk in mds
Published 8 years ago • 451 plays • Length 9:52Download video MP4
Download video MP3
Similar videos
-
5:03
factoring in comorbidities in mds risk stratification
-
10:18
classification of high-risk mutations in mds
-
1:51
genomic sequencing and identifying driver mutations in aml and mds
-
4:10
who criteria and diagnosis in mds
-
56:23
mutations in mds - prognostic and therapeutic implications
-
5:17
accurate risk assessment in mds
-
5:10
understanding genetic mutations in mds
-
2:00
genetic mutations and inflammation: understanding the links and improving prognosis in mds
-
6:20
mds risk stratification and treatment
-
6:48
classification and characteristics of mds
-
7:26
mds: understanding disease characteristics and progression
-
1:18
key recurrent mutations in mds
-
1:29
why is understanding genetic mutations and cytogenetics in mds important?
-
1:29:14
clinical implications of genetic mutations in myelodysplastic syndromes
-
2:45
somatic mutations in mds as a diagnostic and prognostic tool
-
52:52
understanding mds mutations and risk scores
-
2:03
molecular pathogenesis and immune dysregulation in mds
-
5:15
mutation-driven therapy in mds
-
2:08
how do my genetic mutations influence mds risk?